Insulin remains the pharmacological treatment of choice in pregnant women with T2DM or gestational diabetes; however, these patients should be referred to speciality centres and require multiple daily injections of insulin,26 and thus are not within scope for this study. This evidence concerns the gene INS and gestational diabetes.